J9393 Injection, fulvestrant (teva)
J-Codes
Also known as: fulvestrant, Faslodex
Injection of fulvestrant from Teva manufacturer. Estrogen receptor antagonist for hormone receptor-positive breast cancer.
Clinical Context
Used for estrogen receptor-positive metastatic breast cancer as monotherapy or with CDK4/6 inhibitors.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.